Effects of metoprolol in patients with chronic heart failure complicated chronic atrial fibrillation
Ding Chuen-hua
Abstract
Ding Chuen-hua
Abstract
Objective: To investigate therapeutic effects of metoprolol combined with digoxin in patients with chronic heart failure(CHF) complicated chronic atrial fibrillation(AF).Methods: A total of 106 CHF + chronic AF patients were randomly divided into metoprolol + digoxin group(n=52) and digoxin group(n=54).Short-term effects in one month and rehospitalization rate and cardiac mortality rate within one year were observed in two groups.Results:After treatment one month,compared with digoxin group,there were significant decrease in rest ventricular rate [(91.6±8.5) times min vs.(72.8±9.7) times min]and ventricular rate difference immediately before and after exercise [(23.1±4.2) times min vs.(12.3±4.7) times min]and significant increase in 6min walking distance [6MWD,(256.4±90.4) m vs.(299.8±94.1) m]in metoprolol + digoxin group,P0.05 all;Compared with digoxin group after one-year follow-up,there were significant decrease in rehospitalization rate(42.6% vs.19.2%) and mortality rate caused by heart failure(20.4% vs.11.5%),left ventricular end-diastolic volume and left ventricular end-systolic volume;significant increase in 6MWD and left ventricular ejection fraction,and significant improvement in New York heart association class and scores of quality of life in metoprolol + digoxin group,P0.05 all.Conclusion: Based on routine therapy,digoxin combined with metoprolol possesses more effects than that of digoxin treatment in one month and one year
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate therapeutic effects of metoprolol combined with digoxin in patients with chronic heart failure(CHF) complicated chronic atrial fibrillation(AF).Methods: A total of 106 CHF + chronic AF patients were randomly divided into metoprolol + digoxin group(n=52) and digoxin group(n=54).Short-term effects in one month and rehospitalization rate and cardiac mortality rate within one year were observed in two groups.Results:After treatment one month,compared with digoxin group,there were significant decrease in rest ventricular rate [(91.6±8.5) times min vs.(72.8±9.7) times min]and ventricular rate difference immediately before and after exercise [(23.1±4.2) times min vs.(12.3±4.7) times min]and significant increase in 6min walking distance [6MWD,(256.4±90.4) m vs.(299.8±94.1) m]in metoprolol + digoxin group,P0.05 all;Compared with digoxin group after one-year follow-up,there were significant decrease in rehospitalization rate(42.6% vs.19.2%) and mortality rate caused by heart failure(20.4% vs.11.5%),left ventricular end-diastolic volume and left ventricular end-systolic volume;significant increase in 6MWD and left ventricular ejection fraction,and significant improvement in New York heart association class and scores of quality of life in metoprolol + digoxin group,P0.05 all.Conclusion: Based on routine therapy,digoxin combined with metoprolol possesses more effects than that of digoxin treatment in one month and one year
Key concepts: Digoxin, Medicine, Metoprolol, Cardiology, Atrial fibrillation, Internal medicine, Ejection fraction, Heart failure